CIMS Introduces DMC-HUB for Managing Data Monitoring Committees

SOMERSET, N.J. - Jan. 25, 2024 - PRLog -- CIMS Global, an international leader of software and services supporting clinical trials, announces today a new approach to managing DMC (Data Monitoring Committee) activities for pharmaceutical sponsors and CRO's, the Data Monitoring Committee HUB (DMC-HUB).
The DMC-HUB stands as a comprehensive platform designed to streamline every facet of the Data Monitoring Committee (DMC) process. This includes central documentation, scheduling, meeting coordination, management, and post-meeting actions. Beyond its centralized management capabilities, the DMC-HUB boasts an innovative feature – Dynamic Data Monitoring (DDM™). Leveraging state-of-the-art statistical methods, DDM dynamically presents the cumulative treatment effects (efficacy and safety) on our proprietary clinical trial "radar screen." This groundbreaking visualization empowers the DMC to make well-informed recommendations based on real-time trial status, determining whether trials should be accelerated, adjusted, or even terminated. Additionally, CIMS contributes statistical service expertise, reinforcing the DMC process with unparalleled support.
"Integrated with Dynamic Data Monitoring, the DMC-HUB introduces a level of visibility that was previously unattainable," said Tai Xie, Ph.D., Founder and CEO of CIMS Global. "Data Monitoring Committee members and clinicians now have the empowerment to efficiently manage and anticipate results, enabling them to provide more informed and impactful recommendations. We are thrilled to launch this innovation into the market, contributing to the transformation of the future of clinical trials – a vision that lies at the core of our company's foundation."

DMC-HUB features:

• A central home for DMC documentation and workflows for reviewing data.
• Dynamic Data Monitoring (DDM™) to quickly predict trial outcomes.
• Live support from a team of experts in the pharmaceutical, academic research, and regulatory affairs fields.
• Improved transparency and insight into clinical trial data.

Lear more at https://cims-global.com/

About CIMS Global

With over 16 years of industry experience, CIMS Global has pioneered the reshaping of clinical trials with novel technology, streamlining and creating pathways to life-saving therapies. CIMS bridges the gap between researchers and effective treatments with significant cost-savings, speed and reliable data powered by a comprehensive platform.  AI and machine learning unlock hidden insights, optimize trial design, and allow for faster, data-driven decisions. This integrated ecosystem connects every step of the trial, enabling real-time monitoring, proactive safety adjustments, and dynamic course correction. CIMS primary focus lies in creating novel tools that accelerate breakthroughs, enabling more drugs to reach the market faster, improving patient outcomes.